Newsfeeds - Spark Newswire

2 minute read

FDA
News

Freeline Announces Orphan Drug Designations for FLT201 for the Treatment of Gaucher Disease

Today, 7:52 AM

Freeline Therapeutics Holdings plc (NASDAQ:FRLN) (the “Company” or “Freeline”), a clinical-stage biotechnology company developing transformative AAV-mediated gene therapies for patients suffering

FRLN

1 minute read

10 Biggest Price Target Changes For Wednesday

By Lisa Levin

Today, 7:52 AM

Barclays lifted Walmart Inc. (NYSE: WMT) price target from $165 to $170. Walmart shares rose 0.1% to $150.78 in pre-market trading.

1 minute read

HC Wainwright & Co. Maintains Buy on Freeline Therapeutics, Lowers Price Target to $20

By Benzinga Newsdesk

Today, 7:52 AM

HC Wainwright & Co. analyst Patrick Trucchio maintains Freeline Therapeutics (NASDAQ:FRLN) with a Buy and lowers the price target from $30 to $20.

FRLN

9 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For August 17, 2021

By Benzinga Insights

Today, 7:52 AM

ACGL

1 minute read

JP Morgan Downgrades Freeline Therapeutics to Neutral, Lowers Price Target to $8

By Benzinga Newsdesk

Today, 7:52 AM

JP Morgan analyst Eric Joseph downgrades Freeline Therapeutics (NASDAQ:FRLN) from Overweight to Neutral and lowers the price target from $27 to $8.

FRLN

8 minute read

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business

By Shanthi Rexaline

Today, 7:52 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16)

ABSI

14 minute read

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 7:52 AM

On Monday morning, 207 companies hit new 52-week lows.

ACAD

6 minute read

78 Biggest Movers From Friday

By Lisa Levin

Today, 7:52 AM

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported closing of $15-million public offering.

ABCL